Going concern
Filing comparison
CNS Pharmaceuticals, Inc. no longer discloses a going-concern conclusion
Substantial doubt raised, alleviated by management's plans → No going-concern disclosure
Evidence
- Caveat
- None
- Comparable
- True
- Current state
- none
- Current state label
- No going-concern disclosure
- Direction
- eased
- Located in
- Prior filed
- 2026-05-14
- Prior form
- 10-Q
- Prior state
- doubt_alleviated
- Prior state label
- Substantial doubt raised, alleviated by management's plans
- Registrant changed from
- None
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.